Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010

Validity of Parent-Reported Vaccination Status for Adolescents Aged 13–17 Years: National Immunization Survey-Teen, 2008

(2017) Christina G. Dorell et al.   PUBLIC HEALTH REPORTS

Prevalence of Anogenital Warts Among Participants in Private Health Plans in the United States, 2003–2010: Potential Impact of Human Papillomavirus Vaccination

(2013) Elaine W. Flagg et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women

(2013) Simon R. M. Dobson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

(2012) S. N. Tabrizi et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccine-Type Human Papillomavirus and Evidence of Herd Protection After Vaccine Introduction

(2012) J. A. Kahn et al.   PEDIATRICS

Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States

(2012) Harrell W. Chesson et al.   VACCINE

Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study

(2011) Francesca Carozzi et al.   EUROPEAN JOURNAL OF CANCER

Human Papillomavirus (HPV) 6, 11, 16, and 18 Prevalence Among Females in the United States—National Health and Nutrition Examination Survey, 2003–2006: Opportunity to Measure HPV Vaccine Impact?

(2011) Eileen F. Dunne et al.   JOURNAL OF INFECTIOUS DISEASES

Clustering of Multiple Human Papillomavirus Infections in Women From a Population-Based Study in Guanacaste, Costa Rica

(2011) Salvatore Vaccarella et al.   JOURNAL OF INFECTIOUS DISEASES

Prevalence of Genital Human Papillomavirus Among Females in the United States, the National Health and Nutrition Examination Survey, 2003–2006

(2011) Susan Hariri et al.   JOURNAL OF INFECTIOUS DISEASES

Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease

(2011) Anil K. Chaturvedi et al.   JOURNAL OF INFECTIOUS DISEASES

Clustering of Human Papillomavirus (HPV) Types in the Male Genital Tract: The HPV in Men (HIM) Study

(2011) Salvatore Vaccarella et al.   JOURNAL OF INFECTIOUS DISEASES

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

(2011) Aimée R. Kreimer et al.   JNCI-Journal of the National Cancer Institute

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

(2011) Cosette M Wheeler et al.   LANCET ONCOLOGY

The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme

(2011) T. R. H. Read et al.   SEXUALLY TRANSMITTED INFECTIONS

Estimating Model-Adjusted Risks, Risk Differences, and Risk Ratios From Complex Survey Data

(2010) G. S. Bieler et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Post-licensure monitoring of HPV vaccine in the United States

(2010) Lauri E. Markowitz et al.   VACCINE

A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD®

(2010) Paolo Bonanni et al.   VACCINE

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

(2009) Cosette M. Wheeler et al.   JOURNAL OF INFECTIOUS DISEASES

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

(2009) Darron R. Brown et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY